| Times Pharmacy #6 Waipahu | |
| 94-766 Farrington Hwy, Waipahu, Hawaii 96797 | |
| (808) 677-1513 |
| Name | Times Pharmacy #6 Waipahu |
|---|---|
| Organization Name | Qsi Inc |
| Location | 94-766 Farrington Hwy, Waipahu, Hawaii 96797 |
| Type | Pharmacy |
| Phone | (808) 677-1513 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Valacyclovir Hydrochloride Tablets, 500 mg (base) and 1000 mg (base), the generic version of GlaxoSmithKline's Valtrex, a treatment for the herpes virus infection.
CanProbe, a unique, not-for-profit joint venture to advance the use of medical isotopes for diagnosing and treating cancer and other serious diseases, was announced today by the Centre for Probe Development and Commercialization (CPDC) and the University Health Network.
Published in JAMA Oncology, Principal Investigator of Vall d´Hebron Institute of Oncology´s Translational Genomics Group, Team Leader of translational genomics and targeted therapeutics in solid tumors at the August Pi I Sunyer Biomedical Research Institute, and Head of Medical Oncology at the Hospital Clínic in Barcelona, Aleix Prat has led a study showing the intrinsic subtyping of breast cancer by means of a genomic test as the most important prognostic factor in advanced or metastatic hormone-sensitive breast cancer.
A third of patients with advanced or metastatic melanoma will achieve an objective response to treatment with the programmed cell death protein inhibitor pembrolizumab, suggest KEYNOTE-001 findings, regardless of whether they have previously been treated with ipilimumab.
› Verified 6 days ago
| NPI Number | 1871691808 |
| Organization Name | QSI INC |
| Doing Business As | TIMES PHARMACY #6 |
| Type | Pharmacy |
| Address | 94 766 Farrington Hwy, Waipahu, HI 96797 |
| Phone Number | 808-677-1513 |
News Archive
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Valacyclovir Hydrochloride Tablets, 500 mg (base) and 1000 mg (base), the generic version of GlaxoSmithKline's Valtrex, a treatment for the herpes virus infection.
CanProbe, a unique, not-for-profit joint venture to advance the use of medical isotopes for diagnosing and treating cancer and other serious diseases, was announced today by the Centre for Probe Development and Commercialization (CPDC) and the University Health Network.
Published in JAMA Oncology, Principal Investigator of Vall d´Hebron Institute of Oncology´s Translational Genomics Group, Team Leader of translational genomics and targeted therapeutics in solid tumors at the August Pi I Sunyer Biomedical Research Institute, and Head of Medical Oncology at the Hospital Clínic in Barcelona, Aleix Prat has led a study showing the intrinsic subtyping of breast cancer by means of a genomic test as the most important prognostic factor in advanced or metastatic hormone-sensitive breast cancer.
A third of patients with advanced or metastatic melanoma will achieve an objective response to treatment with the programmed cell death protein inhibitor pembrolizumab, suggest KEYNOTE-001 findings, regardless of whether they have previously been treated with ipilimumab.
› Verified 6 days ago
News Archive
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Valacyclovir Hydrochloride Tablets, 500 mg (base) and 1000 mg (base), the generic version of GlaxoSmithKline's Valtrex, a treatment for the herpes virus infection.
CanProbe, a unique, not-for-profit joint venture to advance the use of medical isotopes for diagnosing and treating cancer and other serious diseases, was announced today by the Centre for Probe Development and Commercialization (CPDC) and the University Health Network.
Published in JAMA Oncology, Principal Investigator of Vall d´Hebron Institute of Oncology´s Translational Genomics Group, Team Leader of translational genomics and targeted therapeutics in solid tumors at the August Pi I Sunyer Biomedical Research Institute, and Head of Medical Oncology at the Hospital Clínic in Barcelona, Aleix Prat has led a study showing the intrinsic subtyping of breast cancer by means of a genomic test as the most important prognostic factor in advanced or metastatic hormone-sensitive breast cancer.
A third of patients with advanced or metastatic melanoma will achieve an objective response to treatment with the programmed cell death protein inhibitor pembrolizumab, suggest KEYNOTE-001 findings, regardless of whether they have previously been treated with ipilimumab.
› Verified 6 days ago
5 Minute Pharmacy, Llc Type: Specialty Pharmacy Location: 94-216 Farrington Hwy, Waipahu, Hawaii 96797 Phone: (808) 677-5550 | |
Ace Medical Inc Type: DME Supplier - Customized Equipment Location: 94-910 Moloalo St, Waipahu, Hawaii 96797 Phone: (808) 678-3600 | |
Ec Home Aid Supply, Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 94-216 Farrington Hwy, Waipahu, Hawaii 96797 Phone: (808) 389-9883 | |
Hawaiian Eye Optical Type: Medicare Supplier Location: 94-673 Kupuohi St, Waipahu, Hawaii 96797 Phone: (808) 678-0622 | |
Longs Drugs #09259 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 94-060 Farrington Hwy 6, Waipahu, Hawaii 96797 Phone: (808) 676-8116 |